OTC Markets EXMKT - Delayed Quote USD

Biostar Pharmaceuticals, Inc. (BSPM)

0.0001
0.0000
(0.00%)
At close: May 23 at 9:30:15 AM EDT
Loading Chart for BSPM
  • Previous Close 0.0001
  • Open 0.0001
  • Bid --
  • Ask --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0000 - 0.0010
  • Volume 20,000
  • Avg. Volume 1,255
  • Market Cap (intraday) 316,463
  • Beta (5Y Monthly) -4,377.96
  • PE Ratio (TTM)
  • EPS (TTM) 0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides 12 other OTC products and 17 prescription-based pharmaceuticals. The company's OTC products also comprise Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. Its prescription pharmaceutical products include Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. The company also operates a Website that serves as Internet-based China Hepatitis Internet hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. Biostar Pharmaceuticals, Inc. sells its products through distributors and a network of sales people in approximately 28 provinces. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.

200

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BSPM

View More

Performance Overview: BSPM

Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BSPM
90.00%
S&P 500 (^GSPC)
1.34%

1-Year Return

BSPM
0.00%
S&P 500 (^GSPC)
10.16%

3-Year Return

BSPM
0.00%
S&P 500 (^GSPC)
46.03%

5-Year Return

BSPM
99.86%
S&P 500 (^GSPC)
96.34%

Compare To: BSPM

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BSPM

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    294.01%

  • Return on Assets (ttm)

    4.25%

  • Return on Equity (ttm)

    2.66%

  • Revenue (ttm)

    317.79k

  • Net Income Avi to Common (ttm)

    934.35k

  • Diluted EPS (ttm)

    0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    364.97k

  • Total Debt/Equity (mrq)

    6.71%

  • Levered Free Cash Flow (ttm)

    7.47M

Research Analysis: BSPM

View More

Company Insights: BSPM

Research Reports: BSPM

View More

People Also Watch